Geovax Labs Inc (GOVX)
1.80
-0.12
(-6.25%)
USD |
NASDAQ |
Nov 04, 16:00
1.81
+0.01
(+0.56%)
After-Hours: 20:00
Geovax Labs Debt to Equity Ratio: -0.0616 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.0616 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.0094 |
| December 31, 2020 | 0.0207 |
| September 30, 2020 | 0.0186 |
| June 30, 2020 | -0.3459 |
| March 31, 2020 | -0.0198 |
| December 31, 2019 | -0.0252 |
| September 30, 2019 | -0.0408 |
| June 30, 2019 | -0.0337 |
| March 31, 2019 | -0.0397 |
| December 31, 2018 | -0.2934 |
| September 30, 2018 | -0.069 |
| June 30, 2018 | -0.0673 |
| Date | Value |
|---|---|
| March 31, 2018 | -0.3879 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.3459
Minimum
Jun 2020
0.0207
Maximum
Dec 2020
-0.0213
Average
--
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions Inc | 2.232 |
| Tonix Pharmaceuticals Holding Corp | 0.2016 |
| Abbott Laboratories | 0.3764 |
| SIGA Technologies Inc | 0.00 |
| Chimerix Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.095M |
| Total Liabilities (Quarterly) | 6.404M |
| Shareholders Equity (Quarterly) | -2.309M |
| Current Ratio | 0.6001 |
| Net Debt Paydown Yield | -0.21% |